Denosumab for Prevention of Bone Complications After Bone Marrow Transplantation in Children

NCT02677246 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of funding

Conditions

Disorder Related to Bone Marrow Transplantation

Interventions

DRUG: Denosumab

Sponsor

St. Justine's Hospital